HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Money

Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus

The 185-acre site will be the company’s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.

By BioPharma Dive · Apr 23, 2026 · via BioPharma Dive
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus

Image: BioPharma Dive

This is an aggregated industry headline. Read the full story at BioPharma Dive →

Tags
moneyformat:headlineheadlineBioPharma Dive
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Money
All Money →
Roche Sits Out $29B Pharma Buying Frenzy, Citing Debt and Discipline
Money
Roche Sits Out $29B Pharma Buying Frenzy, Citing Debt and Discipline
As peers spent $29B in late-March M&A, Roche CEO Thomas Schinecker said high rates, no patent cliffs, and 19 d…
Apr 27, 2026
Avalyn’s $182M IPO: Leaning on Re‑Formulation to Reprice Old IPF Drugs
Money
Avalyn’s $182M IPO: Leaning on Re‑Formulation to Reprice Old IPF Drugs
Avalyn Pharma plans a $182M IPO to fund late‑stage trials for inhaled pirfenidone and nintedanib, signaling in…
Apr 25, 2026
MoneyBioPharma Dive ↗
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral…
Apr 24, 2026